SOURCE: Wall Street News Alert

April 11, 2006 09:46 ET

Stock Alert: Emerging Public Company Completes Acquisition of the California Institute of Cosmetic and Reconstructive Surgery! April 11, 2006

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL -- (MARKET WIRE) -- April 11, 2006 -- Wall Street News Alert's "stocks to watch" this morning are: Healtheuniverse Inc. (OTC: HLUN), Pfizer Inc. (NYSE: PFE), Generex Biotechnology Corp (NASDAQ: GNBT) and Novavax Inc (NASDAQ: NVAX).

Healtheuniverse Inc. (OTC: HLUN) may be a target of aggressive investors and day traders this morning! Yesterday after the stock markets closed, the company, a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, issued a press release announcing that it has completed the acquisition of the assets, operations and clinical database of The California Institute of Cosmetic & Reconstructive Surgery.

News of the acquisition should get the attention of investors! The acquisition includes the CICRS clinical database which expands and advances the Company's capacity for evidenced based human clinical trials for stem cell applications in the plastic, reconstructive, and cosmetic surgery market. This acquisition marks a significant benchmark in the Companies progress to be the first to commercialize the use of regenerative medicine and adult stem cells.

Investors should continue to watch Healtheuniverse! Services at the California Institute of Cosmetic & Reconstructive Surgery range from the latest techniques in Cosmetic Surgery to extensive new developments in the field of Reconstructive Surgery. The Institute performs Cosmetic Surgery such as breast augmentation, facelifts, liposuction, and rhinoplasty, as well as extensive Reconstructive Surgery for Breast Cancer, burn victims, trauma victims, chronic wounds, skin cancer, and hand surgery.

Wall Street News Alert Continues to place Investors on alert to monitor the progress of Healtheuniverse! Dr Vipul Dev MD, Chief Executive Officer of Healtheuniverse, Inc., stated, "The successful completion of the acquisition of CICRS is a significant milestone in the growth of Healtheuniverse. With substantial growth in the area of plastic and reconstructive surgery and our adult stem cell research moving towards clinical trials the n the progrewe believe the acquisition is a cornerstone to our developmentour ownershipur adult stem cell reserach. We are now moving forward with our plans to accelerate development of our non-embryonic stem cell therapies, which should result in advancement of the technology and value for our shareholders."

Revenue and Earnings from the acquisition will be reflected in the 2nd quarter financials and is expected to be accretive to earnings.

Prior to the latest press release, the stock closed yesterday at Nineteen cents a share.

For an in-depth profile of Healtheuniverse Inc., visit

To view all of Wall Street News Alert's special early morning trading alerts for this morning, visit, where you may also sign up to receive free email alerts in advance of our press releases being issued.

In case you are not familiar with the company: HEALTHeUNIVERSE Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. The company is engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications.

Pfizer Inc. (NYSE: PFE) down 0.1% on 18.3 million shares traded.

Pfizer Inc. is a drug manufacturing company.

Generex Biotechnology Corporation (NASDAQ: GNBT) up 2.6% on 9.9 million shares traded. Generex is engaged in the research and development of drug delivery systems and technologies.

Novavax, Inc. (NASDAQ: NVAX) down 13.4% on 16.4 million shares traded.

Novavax is focused on creating differentiated, value-added pharmaceutical and vaccine products and technologies.


"Alcoa gave quarterly results and the first-quarter reporting period really kicks-off this week as U.S. companies, analysts and economists predict, will be showing solid results. However, interest rate worries are in the near future; the 10-year Treasury note is at 4.97% and the 30-year note is at 5%, plus the increased cost of oil and energy will be a factor in future earnings. Nationally, the average cost of gasoline is at $2.67 for regular unleaded, up by 17 cents in the last 2 weeks alone," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at:

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 50 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at and select the "join now" button.

*** Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street! If you receive any such fax, please do not contact us at You may wish to inquire about the fax, with the CEO of the company that the fax is written about ***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been compensated Forty Thousand Dollars for coverage of Healtheuniverse Inc. (OTC: HLUN), by a third party (CLX & Associates Inc.), who is non-affiliated and may hold a significant position in the stock, for services provided including dissemination of company information in this release. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact Information